NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides...

NanoLogix Inc. Presents at the National Hydrogen Association Conference &
Provides Operations, Management and Director Update

HUBBARD, Ohio, March 31 /PRNewswire-FirstCall/ -- NanoLogix, Inc.
(OTC: NNLX - News) a nano-biotechnology company is pleased to provide the
following updates on company events:
NanoLogix personnel are manning a booth and presenting at the National
Hydrogen Association Expo in Sacramento this week, with the company being
represented by William Hartman and Chris Novak. Mr. Hartman will be presenting
in the Exhibition Hall today, March 31, from 2:00-2:30 pm, on "Biohydrogen and
Electricity Production from Waste Water".
Company CEO Bret Barnhizer was Marlene Bourne's guest on The Bourne Report
March 16, on the topic of Hydrogen Power. The interview provides updates on
hydrogen bioreactor operations. Access: http://www.bournereport.com/radio.php
Work on BNC and BNP development for fast microorganism detection is
proceeding at a rapid pace, with a new patent application filed in March and
positive developments with both the Departments of Defense and Homeland
Security in late February.
Director and Management changes: Dr. Robert Ollar and John Chatterton have
joined the Board of Directors. Dr. Ollar is cofounder of NanoLogix (as
Infectech), the primary author of the majority of the company's granted
patents, and returns to the company after a six year hiatus. Mr. Chatterton is
former co-host of the History Channel series, Deep Sea Detectives, and is one
of the world's most accomplished and well known underwater explorers. David
Barnhizer has joined the company as General Counsel, bringing to the company
nearly forty years of legal expertise. Detailed director and management team
information can be accessed at: http://www.nanologixinc.com/index-2.html
General Counsel David Barnhizer stated: "NNLX is poised to make a
significant move forward under its new board of directors and management team
headed by CEO and Board Chairman Bret Barnhizer and complemented by a reformed
and greatly strengthened board of directors. A skilled and knowledgeable team
of professionals whose members are fully dedicated to the advancement of
NanoLogix has been put into place. As NNLX General Counsel I am extremely
pleased to be associated with a group of professionals committed to the
building of an exceptional company whose patented technologies are on the
cutting edge of hydrogen energy extraction from industrial and commercial
wastes, as well as diagnostic tools that are drawing the attention of
governmental and commercial institutions."
The company has accepted the resignations of directors Hartman, Allan, and
Cavallo from all positions held. Mr. Hartman will continue to provide business
consulting services to NanoLogix.
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development, and
commercialization of nano-biotechnologies, applications and processes. The
Company has 31 granted Patents and multiple Patents Pending for bioreactor-
based Hydrogen Production, revolutionary rapid medical testing technologies,
and bioremediation. Information on NanoLogix is available at
www.nanologixinc.com.
This press release contains statements, which may constitute "forward-
looking statements" within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by the Private Securities
Litigation Reform Act of 1995. Those statements include statements regarding
the intent, belief or current expectations of NanoLogix, Inc., and members of
its management as well as the assumptions on which such statements are based.
Prospective investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and uncertainties,
and that actual results may differ materially from those contemplated by such
forward-looking statements. The Company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions, the
occurrence of unanticipated events or changes to future operating results.
Contact:
Investor Relations
Bret Barnhizer, CEO
Telephone: 330-534-0800
E-mail: Bret@nanologixinc.com

SOURCE NanoLogix, Inc.

Investor Relations, Bret Barnhizer, CEO, NanoLogix, Inc., +1-330-534-0800,
Bret@nanologixinc.com